Asia-Pacific Emerging Infectious Disease Diagnostics Market - Analysis and Forecast, 2023-2033
Introduction to Asia-Pacific Emerging Infectious Disease Diagnostics Market
The Asia-Pacific emerging infectious disease diagnostics market was valued at $4.41 billion in 2022 and is expected to reach $10.83 billion by 2033, growing at a CAGR of 8.65% between 2023 and 2033. A number of factors are driving the growing infectious disease diagnostics market's expansion in the Asia-Pacific area. The financial burden of infectious diseases, support from governments in the form of partnerships and financing, the growing demand for rapid and thorough testing, and developments in molecular diagnostics technology are some of these causes.
Market IntroductionIn the APAC market, diagnostics for infectious diseases comprise a variety of approaches and procedures used to identify and find infectious agents in people who may be infected. These diagnostics are essential for prompt treatment decisions, accurate disease diagnosis, and the execution of public health initiatives.
Microbiological culture is one of the basic methods used in the diagnosis of infectious diseases. To isolate and identify certain pathogens, patient specimens are cultured on specialized growth media. Healthcare professionals can identify the causing organism and evaluate its antibiotic susceptibility by doing this.
Molecular diagnostics is a key strategy in the APAC industry. This entails detecting the genetic makeup of the infectious pathogen using methods like nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR). This enables the highly sensitive and specific identification of pathogens, even at low concentrations.
Market Segmentation:Segmentation 1: by ApplicationLaboratory Testing
Point-of-Care Testing
Segmentation 2: by TechnologyPolymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Next-Generation Sequencing (NGS)
Immunodiagnostics
Other Technologies
Segmentation 3: by Type of InfectionBacterial
Viral
Fungal
Other Infections
Segmentation 4: by Disease TypeRespiratory Infections
Sexually Transmitted Infections (STIs)
Gastrointestinal Infections
Other Infections
Segmentation 5: by End UserHospitals and Clinics
Diagnostic Laboratories
Other End Users
Segmentation 6: by RegionAsia-Pacific - Japan, China, India, South Korea, Australia, Rest-of-Asia-Pacific
How Can This Report Add Value to an Organization?Product/Innovation Strategy:The Asia-Pacific emerging infectious disease diagnostics market has been extensively segmented on the basis of various categories, such as application, technology, type of infection, disease type, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy:The Asia-Pacific emerging infectious disease diagnostics market is fragmented, with several established as well as emerging players. Key players in the Asia-Pacific emerging infectious disease diagnostics market analyzed and profiled in the study involve established players that offer various kinds of molecular diagnostic tests for infectious diseases.
*PDF email from publisher allows for 3-5 users, with permission to print*
Please Note: It will take 7-10 business days to complete the report upon order confirmation.